Targeting Posttranslational Modifications in the Tumor Stromal Microenvironment for Antitumor Therapy

The stromal microenvironment of tumors, comprised of diverse stromal cells and extracellular matrix (ECM), is intricately influenced by multiple signaling pathways, metabolic regulation, and the cell cycle, significantly contributing to tumor malignancy and therapy resistance. Posttranslational modifications (PTMs), crucial mechanisms for regulating protein function in organisms, engage in tumor initiation, progression, metastasis, and therapy resistance by modulating stromal cell behavior, stromal signal transduction, ECM deposition, and remodeling within the tumor stromal microenvironment. This article explores the regulatory role of PTMs within the tumor stromal microenvironment and reviews recent advancements in cancer therapy focused on PTMs. Targeting PTMs within the tumor stromal microenvironment shows promising potential as a novel approach and direction in cancer treatment.

• Publication year

  2025

• Venue

  Molecular Carcinogenesis

• Publication date

  2025-08-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/mc.70030PMID 40831247
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glycosylation: mechanisms, biological functions and clinical implications

  2024cited by this paper
• Mechanisms of assembly and remodelling of the extracellular matrix

  2024cited by this paper
• Receptor tyrosine kinase inhibitors in cancer

  2023cited by this paper
• Functions and mechanisms of lactylation in carcinogenesis and immunosuppression

  2023cited by this paper
• Passing the post: roles of posttranslational modifications in the form and function of extracellular matrix

  2023cited by this paper
• Transcriptional regulation of EMT transcription factors in cancer.

  2023cited by this paper
• Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions

  2023cited by this paper
• lncRNA BREA2 promotes metastasis by disrupting the WWP2-mediated ubiquitination of Notch1

  2023cited by this paper
• PDPN positive CAFs contribute to HER2 positive breast cancer resistance to trastuzumab by inhibiting antibody-dependent NK cell-mediated cytotoxicity.

  2023cited by this paper
• Cancer statistics, 2023

  2023cited by this paper
• Lactate, histone lactylation and cancer hallmarks

  2023cited by this paper
• Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments

  2023cited by this paper
• Targeting the tumor microenvironment: Potential strategy for cancer therapeutics.

  2023cited by this paper
• OUP accepted manuscript

  2022cited by this paper
• The USP18-FBXO6 axis maintains the malignancy of ovarian cancer.

  2022cited by this paper
• Disulfiram prevents collagen crosslinking and inhibits renal fibrosis by inhibiting lysyl oxidase enzymes

  2022cited by this paper
• Targeting the tumor stroma for cancer therapy

  2022cited by this paper
• Targeted immunotherapy against distinct cancer-associated fibroblasts overcomes treatment resistance in refractory HER2+ breast tumors

  2022cited by this paper
• Cancer-associated Fibroblasts: Origin, Function, Imaging, and Therapeutic Targeting.

  2022cited by this paper
• Recent research and development of inhibitors targeting sentrin-specific protease 1 for the treatment of cancers.

  2022cited by this paper
• SENP1 promotes triple-negative breast cancer invasion and metastasis via enhancing CSN5 transcription mediated by GATA1 deSUMOylation

  2022cited by this paper
• Impact of post-translational modification on the genesis and progression of diseases.

  2022cited by this paper
• Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-β signaling in regulatory T cells.

  2022cited by this paper
• Targeting matrix metalloproteinases by E3 ubiquitin ligases as a way to regulate the tumor microenvironment for cancer therapy.

  2022influential reference
• Oxidative stress-CBP axis modulates MOB1 acetylation and activates the Hippo signaling pathway

  2022cited by this paper
• Pathological implication of protein post-translational modifications in cancer.

  2022cited by this paper
• Targeting TGF-β signal transduction for fibrosis and cancer therapy

  2022cited by this paper
• Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model

  2022cited by this paper
• Disruption of pancreatic stellate cell myofibroblast phenotype promotes pancreatic tumor invasion

  2022cited by this paper
• Targeted Therapy Modulates the Secretome of Cancer-Associated Fibroblasts to Induce Resistance in HER2-Positive Breast Cancer

  2021cited by this paper
• 3,3′-Diindolylmethane Promotes Gastric Cancer Progression via β-TrCP-Mediated NF-κB Activation in Gastric Cancer-Derived MSCs

  2021cited by this paper
• ZNF451 stabilizes TWIST2 through SUMOylation and promotes epithelial-mesenchymal transition.

  2021cited by this paper
• LATS1 K751 acetylation blocks activation of Hippo signalling and switches LATS1 from a tumor suppressor to an oncoprotein

  2021cited by this paper
• A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker

  2021cited by this paper
• Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response

  2021cited by this paper
• ALCAP2 inhibits lung adenocarcinoma cell proliferation, migration and invasion via the ubiquitination of β-catenin by upregulating the E3 ligase NEDD4L

  2021cited by this paper
• Extracellular matrix-based cancer targeting.

  2021cited by this paper
• Hallmarks of response, resistance, and toxicity to immune checkpoint blockade.

  2021cited by this paper
• Targeting the acetylation signaling pathway in cancer therapy.

  2021cited by this paper
• Regulation of Hedgehog Signal Transduction by Ubiquitination and Deubiquitination

  2021cited by this paper
• Matrix Metalloproteinases Shape the Tumor Microenvironment in Cancer Progression

  2021cited by this paper
• Therapeutic Targeting of the Tumor Microenvironment.

  2021cited by this paper
• Targeting the Ubiquitin Signaling Cascade in Tumor Microenvironment for Cancer Therapy

  2021cited by this paper
• The matrix in cancer

  2021cited by this paper
• Targeting P4HA1 with a Small Molecule Inhibitor in a Colorectal Cancer PDX Model

  2020cited by this paper
• Knockdown of ubiquitin-specific protease 51 attenuates cisplatin resistance in lung cancer through ubiquitination of zinc-finger E-box binding homeobox 1

  2020cited by this paper
• The updated landscape of tumor microenvironment and drug repurposing

  2020cited by this paper
• Stromal metalloproteinases: Crucial contributors to the tumor microenvironment

  2020cited by this paper
• Addressing cancer’s grand challenges

  2020cited by this paper
• Transcriptional co-activators YAP/TAZ: Potential therapeutic targets for metastatic breast cancer.

  2020cited by this paper
• Tumor microenvironment as a therapeutic target in cancer.

  2020cited by this paper
• Metabolism in the Tumor Microenvironment

  2020cited by this paper
• Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway.

  2020cited by this paper
• A framework for advancing our understanding of cancer-associated fibroblasts

  2020cited by this paper
• Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance

  2019cited by this paper
• Mechanism for oral tumor cell lysyl oxidase like-2 in cancer development: synergy with PDGF-AB

  2019cited by this paper
• Decoding the PTM-switchboard of Notch

  2019cited by this paper
• LOX inhibition downregulates MMP-2 and MMP-9 in gastric cancer tissues and cells

  2019cited by this paper
• Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m6A reader YTHDF3

  2019cited by this paper
• Metabolic regulation of gene expression by histone lactylation

  2019cited by this paper
• Impact of Epithelial-Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ.

  2019cited by this paper
• Ascorbate inducible N259 glycans on prolyl 4-hydroxylase subunit α1 promote hydroxylation and secretion of type I collagen

  2019cited by this paper
• The lysyl oxidase like 2/3 enzymatic inhibitor, PXS‐5153A, reduces crosslinks and ameliorates fibrosis

  2018cited by this paper
• Targeting the tumour stroma to improve cancer therapy

  2018cited by this paper
• The tyrosine phosphatase SHP2 controls TGFβ-induced STAT3 signaling to regulate fibroblast activation and fibrosis

  2018cited by this paper
• p53–Pirh2 Complex Promotes Twist1 Degradation and Inhibits EMT

  2018cited by this paper
• Role of Extracellular Matrix in Development and Cancer Progression

  2018cited by this paper
• Small-Molecule Inhibitors Targeting Protein SUMOylation as Novel Anticancer Compounds

  2018cited by this paper
• TGFβ-Activated USP27X Deubiquitinase Regulates Cell Migration and Chemoresistance via Stabilization of Snail1.

  2018cited by this paper
• CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1

  2017cited by this paper
• Phosphorylation: Implications in Cancer

  2017cited by this paper
• Control of Collagen Triple Helix Stability by Phosphorylation.

  2017cited by this paper
• Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway.

  2017cited by this paper
• Organelle Specific O-Glycosylation Drives MMP14 Activation, Tumor Growth, and Metastasis.

  2017cited by this paper
• Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer.

  2017cited by this paper
• A small-molecule compound inhibits a collagen-specific molecular chaperone and could represent a potential remedy for fibrosis

  2017cited by this paper
• Ubiquitination of tumor suppressor PML regulates prometastatic and immunosuppressive tumor microenvironment

  2017cited by this paper
• A novel immunotherapy targeting MMP-14 limits hypoxia, immune suppression and metastasis in triple-negative breast cancer models

  2017cited by this paper
• Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets

  2016cited by this paper
• Imipramine blue halts head and neck cancer invasion through promoting F-box and leucine-rich repeat protein 14-mediated Twist1 degradation

  2016cited by this paper
• Histone Modifications and Cancer.

  2016cited by this paper
• Hic-5 Remodeling of the Stromal Matrix Promotes Breast Tumor Progression

  2016cited by this paper
• Glycosylation: a hallmark of cancer?

  2016cited by this paper
• F-box proteins: Keeping the epithelial-to-mesenchymal transition (EMT) in check.

  2016cited by this paper
• SUMOylation and SENP3 regulate STAT3 activation in head and neck cancer

  2016cited by this paper
• The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study

  2016cited by this paper
• PAQR3 enhances Twist1 degradation to suppress epithelial-mesenchymal transition and metastasis of gastric cancer cells.

  2016cited by this paper
• Regulation of Smoothened Trafficking and Hedgehog Signaling by the SUMO Pathway.

  2016cited by this paper
• Types of Ubiquitin Ligases.

  2016cited by this paper
• Notch signalling in context

  2016cited by this paper
• Akt mediated phosphorylation of LARP6; critical step in biosynthesis of type I collagen

  2016cited by this paper
• FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells

  2015cited by this paper
• The pathway of collagen secretion.

  2015cited by this paper
• Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation

  2015cited by this paper
• Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial.

  2015cited by this paper
• YAP and TAZ Take Center Stage in Cancer.

  2015cited by this paper
• Glycosylation in cancer: mechanisms and clinical implications

  2015cited by this paper
• Abstract 4970: USP15 regulates SMURF2 kinetics through C-lobe mediated deubiquitination

  2015cited by this paper
• Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts

  2015cited by this paper
• Acetyl-CoA and the Regulation of Metabolism: Mechanisms and Consequences

  2015cited by this paper

• No citing papers are available for this paper.